AstraZeneca

Astrazeneca Pharma India shares jump 20% on delisting proposal

Astrazeneca Pharma India shares jump 20% on delisting proposal

Stock in AstraZeneca Pharma India jumped to its upper circuit filter of 20 per cent at Rs 1,113 a share in early morning trade on Monday on the National Stock Exchange (NSE) after the drug maker revealed its delisting plan.

AstraZeneca Pharma India's board will meet this Wednesday to discuss a proposal to delist the company's shares from the Indian stock exchanges.

The Indian drug maker received the proposal for delisting of its equity shares from the Indian stock exchanges from its Sweden-based parent firm AstraZeneca Pharmaceuticals AB.

Torrent Pharmaceuticals signs license agreement with AstraZeneca

AstraZeneca-LogoTorrent Pharmaceuticals has singed a supply and licensing agreement with the UK based drug maker AstraZeneca.

AstraZeneca, a $32.8-billion enterprise, is the second biggest drug maker in the UK and seventh-largest pharmaceutical company in the world. The company joined two other major pharmaceutical companies to enter into such as agreement with the Indian firm.